1. Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia 
Olga Nikolajeva, Vanderson Rocha, Robert Danby, Annalisa Ruggeri, Fernanda Volt, Etienne Baudoux, Susana G.Gomez, Gezine Kögler, Jerome Larghero, Lucilla Lecchi, Mar Sanchez Martinez, Cristina Navarrete, Fabienne Pouthiers, Sergio Querol, Chantal Kenzey, Richard Szydlo, Eliane Gluckman, Alejandro Madrigal 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 10, Pages (October 2017)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Probability of relapse at 5 years is identical for patients with acute leukemia who received UCBT from either CMV-seropositive or CMV-seronegative donors (33% and 35%, respectively, P = .7). (B) NRM at 2 years does not differ between patients who received UCB collected from the CMV-seropositive or CMV-seronegative donors (31% and 32%, respectively, P = .5). (C) Rate of 5-year OS is identical in the 2 groups (ie, recipients of CMV-seropositive or -seronegative CBUs; 41% and 38%, respectively, P = .3). (D) Rate of 5-year DFS is identical in the 2 groups (ie, recipients of CMV-seropositive or -seronegative cord blood units; 40% and 37%, respectively, P = .3).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions